> Details

Riedel, Fabian [Author]; Heil, Jörg [Author]; Feißt, Manuel [Author]; Moderow, Mareike [Author]; Au, Alexandra von [Author]; Domschke, Christoph [Author]; Michel, Laura L. [Author]; Schäfgen, Benedikt [Author]; Golatta, Michael [Author]; Hennigs, André [Author]

Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy
  • Contributor: Riedel, Fabian [Author]; Heil, Jörg [Author]; Feißt, Manuel [Author]; Moderow, Mareike [Author]; Au, Alexandra von [Author]; Domschke, Christoph [Author]; Michel, Laura L. [Author]; Schäfgen, Benedikt [Author]; Golatta, Michael [Author]; Hennigs, André [Author]
  • Published: 20 August 2020
  • Published in: Breast cancer research and treatment ; 184(2020), 2, Seite 627-636
  • Language: English
  • DOI: 10.1007/s10549-020-05876-z
  • Identifier:
  • Origination:
  • Footnote:
  • Description: In the ACOSOG Z0011 trial, completing axillary lymph node dissection (cALND) did not benefit patients with T1-T2 cN0 early breast cancer and 1-2 positive sentinel lymph nodes (SLN) undergoing breast-conserving surgery (BCT). This paper reports cALND rates in the clinical routine for patients who had higher (T3-T4) tumor stages and/or underwent mastectomy but otherwise met the ACOSOG Z0011 eligibility criteria. Aim of this study is to determine cALND time trends and non-sentinel axillary metastases (NSAM) rates to estimate occult axillary tumor burden.
  • Access State: Open Access